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Fumarate hydratase (FH) is an enzyme of the tricar-
boxylic acid (TCA) cycle mutated in hereditary and
sporadic cancers. Despite recent advances in under-
standing its role in tumorigenesis, the effects of FH
loss on mitochondrial metabolism are still unclear.
Here, we used mouse and human cell lines to assess
mitochondrial function of FH-deficient cells. We
found that human and mouse FH-deficient cells
exhibit decreased respiration, accompanied by a
varying degree of dysfunction of respiratory chain
(RC) complex I and II. Moreover, we show that fuma-
rate induces succination of key components of the
iron-sulfur cluster biogenesis family of proteins,
leading to defects in the biogenesis of iron-sulfur
clusters that affect complex I function. We also
demonstrate that suppression of complex II activity
is caused by product inhibition due to fumarate accu-
mulation. Overall, our work provides evidence that
the loss of a single TCA cycle enzyme is sufficient
to cause combined RC activity dysfunction.
INTRODUCTION
The tricarboxylic acid (TCA) cycle enzyme fumarate hydratase
(FH) catalyzes the reversible hydration of fumarate to malate.
While homozygous mutations of FH leads to fumaric aciduria
(OMIM: 606812), a lethal metabolic disorder, its heterozygous
mutations cause hereditary leiomyomatosis and renal cell
cancer (HLRCC), a cancer syndrome characterized by uterine
fibroids, cutaneous leiomyoma, and type 2 papillary renal cell
cancer (Tomlinson et al., 2002). The oncogenic properties of FH
loss have been mostly ascribed to the intracellular accumulation1036 Cell Reports 21, 1036–1047, October 24, 2017 ª 2017 The Auth
This is an open access article under the CC BY license (http://creativeof fumarate. High levels of this metabolite inhibit hypoxia induc-
ible factors (HIF) prolyl hydroxylases, leading to HIF stabilization
(Isaacs et al., 2005). Furthermore, fumarate causes the non-enzy-
matic covalent modification of reactive cysteine residues in pro-
teins, a process knownas succination (Alderson et al., 2006). This
novel post-translation modification can alter protein function
(Ternette et al., 2013), and it has been suggested to inactivate
kelch-like ECHassociated protein 1 (KEAP1), leading to the upre-
gulation of an antioxidant responsemediated by the transcription
factor nuclear factor, erythroid 2 like 2 (NFE2L2) (Adam et al.,
2011;Ooi et al., 2011).Wealsodemonstrated that fumarate leads
to the epigenetic suppression of a family of anti-metastatic
microRNAs, MIR200, leading to an epithelial-to-mesenchymal
transition, a phenotypic switch that promotes tumor initiation
and metastasis (Sciacovelli et al., 2016).
Because of its role as key enzyme of the TCA cycle, FH
deficiency leads to profound metabolic changes, including
decreased mitochondrial respiration (Frezza et al., 2011; Yang
et al., 2010, 2012), alteration of TCA cycle functionality (Frezza
et al., 2011), and reversal of the urea cycle (Zheng et al., 2013).
However, the interplay between loss of FH, increased fumarate
levels, and different aspects of mitochondrial biology is still
unclear. Here, we investigate the effects of FH deficiency on
mitochondrial function and show that FH loss leads to a complex
dysregulation of the respiratory chain (RC), by affecting multiple
RC complexes. Our results uncover unexpected bioenergetic
features of FH-deficient cells that could explain their ability to
survive under low oxygen, a condition experienced by areas of
most solid tumors.RESULTS
Loss of FH Leads to Respiratory Dysfunction
We began this investigation by assessing the respiratory pheno-
type of mouse and human FH-deficient cells. Mouse epithelialor(s).
commons.org/licenses/by/4.0/).
Figure 1. Fh1-Deficient Cells Display Defects in RC Complexes I and II
(A) Basal respiration in the indicated mouse cells. Data are normalized for total protein content and displayed as mean ± SEM. One-way ANOVA test was applied
to assess the difference in the groups.
(B) Oxygen consumption rate (OCR) in response to increasing concentrations of FCCP followed by antimycin. Data are normalized for total protein content and
displayed as mean ± SEM.
(C) Cell growth of indicated cell lines in 25 mM galactose (squares) or glucose (circles). Data are represented as mean ± SD.
(D–G) Complex I- (D), complex II- (E), complex III- (F), and complex IV- (G) driven respiration in the indicated cell lines after subtraction of inhibitor-insensitive
respiration values measured after the addition of substrates. Substrates to drive respiration and concentrations of drugs used are indicated in Figure S1. Data
were generated from at least 3 independent experiments and presented as mean ± SEM. One-way ANOVA test was applied to assess the difference in the
groups. n.s., not significant.kidney cells were obtained from Fh1 conditional knockout ani-
mals and included Fh1-proficient cells (Fh1fl/fl) and two Fh1-defi-
cient clones, Fh1/CL1 and Fh1/CL19 (Frezza et al., 2011). An
Fh1-reconstituted cell line (Fh1/+pFh1-GFP) was generated
to determine the effects of restoration of Fh1 activity on an
Fh1-deficient background (Sciacovelli et al., 2016). Human
FH-deficient cell lines included UOK262 (Yang et al., 2010) and
a previously generated FH-reconstituted isogenic cell line,
UOK262pFH (Frezza et al., 2011). In accordance with previous
work (Frezza et al., 2011), Fh1-deficient cells exhibited a
decreased basal respiration (Figure 1A). Furthermore, the proto-
nophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP) failed to increase respiration of Fh1-deficient cells,
indicating a defect in maximal respiratory capacity (Figure 1B).
Importantly, complementation of Fh1 restored normal levels of
basal and maximal respiratory capacity (Figures 1A and 1B),indicating that the respiratory defects are reversible and
depend on Fh1.
The extent of mitochondrial dysfunction was assessed further
by growing cells in a glucose-deficient medium supplemented
with galactose, the catabolism of which enhances oxidative
metabolism. Mouse and human FH-deficient cells could not
grow in the glucose-free galactose-supplemented medium (Fig-
ures 1C and S1A), suggesting that they are unable to further
increase mitochondrial function for energy generation. The
expression of FH in UOK262 cells did not restore their capacity
to grow in galactose (Figure S1A), likely because they maintain
high rates of glycolysis despite restoration of their mitochondrial
function (Frezza et al., 2011). Overall, these results indicate that
the loss of FH causes a profound mitochondrial dysfunction.
We then investigated the mechanisms behind the respiratory
defects in FH-deficient cells. To this end, we measured cellCell Reports 21, 1036–1047, October 24, 2017 1037
respiration upon cell permeabilization with recombinant cyto-
lysin protein (PMP), which selectively permeabilizes the plasma
membrane, but not the mitochondrial membranes (Salabei
et al., 2014), enabling the determination of the activity of individ-
ual RC components. In Fh1-deficient mouse cells, RC complex I
activity was reduced to about 30% of that of Fh1-proficient cells
(Figures 1D and S1B). In addition, Fh1-deficient mouse cells dis-
played a loss of complex II activity (Figures 1E and S1C),
whereas the activity of RC complexes III and IV was not signifi-
cantly altered (Figures 1F, 1G, S1D, and S1E). Compared to
mouse Fh1-deficient cells, UOK262 cells displayed a more pro-
nounced respiratory defect. Indeed, alongside defective RC
complex I and complex II (Figures S1F and S1G), UOK262 cells
exhibited diminished complex IV activity compared to the FH-re-
constituted cell line (Figure S1H). In summary, these data indi-
cate that human and mouse FH-deficient cells exhibit defects
in RC complexes I and II and that the human cells also exhibit
defective RC complex IV.
High Levels of Fumarate Inhibit Complex II but Not
Complex I
The observation that respiration is impaired in PMP-permeabi-
lized Fh1-deficient cells, in which mitochondria are intact but
exposed to exogenous substrates, suggested an intrinsic dysre-
gulation of RC complexes. Importantly, an in-gel flavin-site com-
plex I activity assay performed on blue native gels (Figure 2A)
confirmed intrinsic defects in complex I, whose activity was
reduced to 30% in Fh1-deficient cells. We then tested whether
fumarate, which accumulates at very high levels in these cells,
affects complex I activity. To this aim, isolated mitochondrial
membranes from bovine heart mitochondria were incubated
with increasing doses of fumarate. Neither fumarate nor its
cell-permeable derivative monomethyl-fumarate (MMF) affected
complex I-mediated respiration, even at high concentration (Fig-
ure 2B). These results confirmed the defects in complex I in Fh1-
defcient cells but excluded a direct effect of fumarate on this RC
complex.
We also investigated the effects of fumarate on complex II. To
this end, we measured the succinate-ubiquinone oxidoreduc-
tase (SQR) activity of complex II in cells incubated with a deter-
gent that solubilizes the mitochondrial membranes, releasing
matrix fumarate. Surprisingly, we found that complex II activity
is not decreased in this assay (Figures 2C), in which fumarate
levels are in the low micromolar range in Fh1-deficient cells (Fig-
ure 2D). Fumarate and succinate bind with similar affinity to the
succinate-binding site of succinate dehydrogenase (SDH) A
(Grivennikova et al., 1993). Hence, because the intracellular con-
centration of fumarate in our Fh1-deficient mouse cells is
approximately 10 mM, 10-fold higher than succinate (Frezza
et al., 2011), it is likely that the concentration of fumarate in the
mitochondrial matrix is similarly elevated and that fumarate
blocks the access of succinate to the SDHA active site. Indeed,
we found that SQR activity is markedly decreased by fumarate in
a concentration-dependent fashion (Figure 2E). This inhibition of
SDH by fumarate is consistent with amixed inhibitionmodel (Fig-
ures 2F and 2G), supporting the hypothesis that accumulation of
fumarate decreases SDH-driven respiration in Fh1-deficient
cells by competing with succinate. In summary, these results1038 Cell Reports 21, 1036–1047, October 24, 2017indicate that, while fumarate has no direct inhibitory effects on
complex I, it suppresses complex II activity by product inhibition.
RC Protein Abundance in FH-Deficient Cells
To investigate whether changes in RC activity were associated
with specific depletion of RC complexes, we performed tandem
mass tagging (TMT) quantitative proteomics (McAlister et al.,
2012; Thompson et al., 2003). Overall, we identified and quanti-
fied 87% and 92% of the known RC proteins and assembly fac-
tors in human and mouse cell lines, respectively. The expression
levels of 40 of the 45 complex I subunits were significantly
reduced in UOK262 cells compared to UOK262pFH cells (Fig-
ure S2A). Furthermore, complex II, complex III, and complex IV
showed decreases in abundance of specific subunits (Fig-
ure S2A). These data suggest that respiratory dysfunction in
UOK262 cells is likely the product of a global downregulation
in the content of RC complexes and their assembly factors. To
investigate whether the downregulation of RC complexes
occurred at a transcriptional level, we analyzed mRNA levels of
RC transcripts using a previously published dataset (Sciacovelli
et al., 2016). We observed a global transcriptional downregula-
tion of RC subunits in UOK262 compared to UOK262pFH (Fig-
ure S2B). Interestingly, mtDNA-encoded RC subunits appeared
upregulated in UOK262 (Figure S2B), indicative of a possible
compensatory increase in mitochondrial biomass due to the
overall suppression of nuclear-encoded RC subunits.
To our surprise, there were no significantly depleted RC pro-
teins in Fh1-deficient mouse cells (Figure 3A). Interestingly,
SDHsubunits showed increasedexpressionover control, despite
the fact that complex II makes no contribution toward respiration
in Fh1-deficient cells (Figure 1C). Optical measurement of the
functional content of complex III, cytochrome c, and complex IV
(Kim et al., 2012; Ripple et al., 2013) confirmed that the content
of complex III and cytochrome c does not change, and a 40%
decrease in complex IV was observed (Figure 3B), although
the latter is not reflected either by respiratory defects (Figure 1G)
or by protein abundance (Figure 3A). These data suggest that
the respiratory dysfunction in Fh1-deficient mouse cells cannot
be explained by changes in RC complexes’ abundance and
could be ascribed to protein regulation at the post-translational
level. Therefore, we decided to investigate whether post-
translational modifications could explain the observed profound
respiratory defects in mouse Fh1-deficient cells.
Succination Profile of Mitochondrial Protein in FH-
Deficient Cells
Fumarate accumulation is responsible for a post-translation
modification termed succination, which involves covalent
bonding of fumarate to reactive cysteine residues of proteins
(Alderson et al., 2006; Bardella et al., 2011; Ternette et al.,
2013; Yang et al., 2014). We therefore studied the role of protein
succination in the regulation of the activity of RC complexes.
To this end, we applied a relative quantitative proteomic exper-
iment using TMT. This non-targeted approach identified 563
(442 significantly changed, false discovery rate [FDR] < 5%) suc-
cinated peptides in mouse cells (Figure 4A). Importantly, global
succination decreased significantly after the restoration of Fh1
expression (Figure 4B), in line with the reduction in fumarate
Figure 2. Fumarate Inhibits Complex II, but Not Complex I, Activity
(A) Representative blue native in-gel complex I activity assay in the indicated cell lines. Data were obtained from 3 independent experiments and are presented as
mean ± SEM. One-way ANOVA test was applied using Dunnett’s multiple comparison test.
(B) Complex I activity in mitochondrial membranes from bovine heart in the presence of the indicated concentration of fumarate and monomethyl-fumarate
(MMF). Data are normalized to vehicle-treated condition and presented as mean ± SD from 4 replicates.
(C) Succinate-Quinol Reductase (SQR) activity of complex II in the indicated cell lines. Values are presented as mean ± SEM.
(D) Concentration of fumarate in the SQR assays showed in (C). Values are presented as mean ± SEM.
(E) SQR activity of complex II in the presence of the indicated concentrations of succinate and increasing concentration of fumarate. Values are presented as
mean ± SD.
(F) Michealis-Menten representation of SQR activity of complex II in the presence of different concentrations of fumarate and succinate. Values are presented as
mean ± SD.
(G) Calculated Vmax of complex II and KM of complex II for succinate, as a function of fumarate concentration. Data were obtained from 2 independent
experiments.levels, and restored mitochondrial respiration observed in Fh1-
reconstituted cells. While no RC subunits were identified in the
succinated proteome, we identified succination of multiple
components of the iron-sulfur (Fe-S) cluster biogenesis familyof proteins. Succinated residues were detected on cysteine
213 of the Fe-S Cluster Scaffold Nfu1, on two cysteine residues
(Cys-70 and Cys-139) of the Fe-S cluster assembly enzyme
(Iscu), on cysteine 216 of bolA family member 1 (Bola1), and onCell Reports 21, 1036–1047, October 24, 2017 1039
Figure 3. Abundance of RC Complex Subunits and Assembly Factors in Fh1-Deficient Mouse Cells
(A) Quantitative profile of RC complex subunits and assembly factors in the indicated cell lines. The detected subunits and assembly factors are grouped by RC
complexes. mtDNA-encoded subunits are indicated in red. The combined data of 4 biological replicates run over two independent TMT analyses are presented.
(B) Functional content of complex III, cytochrome c, and complex IV in the indicated cell lines. Values are represented as mean ± SEM. Unpaired t test was used
for statistics.cysteine 110 of Bola3 in Fh1-deficient cells (Figure 4A). Of note,
none of these proteins exhibited significant alterations in their
protein levels (Figure 4C). We then focused on Nfu1, which
was the most significantly succinated protein among the ones
involved in Fe-S cluster biogenesis (Figure 4A). Importantly,
Fh1 re-expression significantly decreased Nfu1 succination
in Fh1/+pFh1-GFP cells (Figure 4D) to a level comparable to
Fh1fl/fl (Figures 4D and 4F). To confirm the link between fumarate
accumulation and succination of Fe-S cluster proteins, we
performed a similar proteomic analysis in human cells. Here
we detected 862 (639 significantly changed, FDR< 5%) peptides
in human FH-deficient cells (Figure S2C). Strikingly, we identified1040 Cell Reports 21, 1036–1047, October 24, 2017NFU1 as one of the succinated proteins in UOK262 cells, and its
levels of succination were rescued upon FH expression in
UOK262pFH (Figure S2C).
The cysteine residues of Iscu and Nfu1 affected by succination
are critical for their enzymatic activity. Consistently, mutations in
these enzymes lead to defects in the early steps of Fe-S biosyn-
thesis and varying degrees of deficiency of the RC complexes
(Navarro-Sastre et al., 2011; Parent et al., 2015). Therefore, we
hypothesized that succination of Iscu/Nfu1/Bola1-3 would, at
least in part, explain the mitochondrial respiratory defects
observed in Fh1-deficient cells. Other mitochondrial enzymes,
including aconitase 2 (Aco2), require correct Fe-S assembly for
Figure 4. Fumarate-Mediated Succination of Fe-S Cluster Biogenesis Enzymes
(A) Volcano plot illustrating the quantitative profile of identified mouse succinated peptides found in Fh1/ (both knockout [KO] clones) compared to Fh1fl/fl cells.
Nfu1, Iscu, Bola1, and Bola3 succinated peptides are indicated. Red dots indicate significantly regulated succinated peptides in Fh1-deficient cells compared to
Fh1-proficient cells.
(B) Polynomial curve representing the distribution of the intensity of succination signal in mouse cells (x) versus counts (y).
(C) Scatterplot showing the levels of total protein changes compared to changes in succination. The succinated peptides display high fold changes (x axis)
whereas the respective total protein levels remain mostly unchanged (y axis). The succinated peptides from Iscu, Nfu1, Bola1, and Bola 3 proteins are
indicated.
(D) Volcano plot of succinated peptides in Fh1/+pFh1-GFP compared to Fh1fl/fl.
(E) Volcano plot of succinated peptides in Fh1/ compared to Fh1/+pFh1-GFP.
(F) Bar graph indicating the reporter intensity relative to the Nfu1 succinated peptide containing C213 in the indicated cell types. Values are represented as
mean ± SEM. One-way ANOVA test followed by Sidak’s multiple comparison test was applied to assess the difference in the groups. n.s., not significant.
(G) Aconitase activity in Fh1-deficent cells (3 biological replicates, values represents mean ± SEM). One-way ANOVA test followed by Dunnett’s multiple
comparison test was applied to assess the difference in the groups.
(H and I) FACS profile (H) and fluorescence intensity of Venus-positive cells (I) of cells of the indicated genotype transfected with mito-Venus-GRX2.
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Figure 5. Fh1-Deficient Cells Display Normal DP but Altered DpH and DJ
(A) TMRE andMTG staining and quantification in the indicated cell lines. Values are presented asmean ±SEM (MTG) or mean ±SD (TMRE). One-way ANOVA test
was applied using Bonferroni multiple comparison test for mouse cells. Unpaired t test was used for UOK262/pFH cells.
(B and C) Multi-wavelength spectrophotometric determination of DJ, DpH, and DP (B) and of the redox state of the ubiquinone/ubiquinol couple, cytochrome c,
and the NAD+/NADH couple (C). Values are presented as mean ± SEM. Unpaired t test was applied. For the DpH graph, 61 mV = 1 pH unit difference.
(D) Respirometry coupled with multi-wavelength spectrophotometric determination of the flux of electrons through complex III. Data were obtained from at
least 3 independent cultures and presented as mean ± SEM. Unpaired t test was applied to assess the difference in the groups. n.s., not significant.their function and can be used as a beacon for Fe-S cluster
biogenesis. Therefore, to validate the downstream effect of
Fe-S imbalance in our cells lines, we measured the activity of
Aco2. Consistently, Aco2 activity was significantly decreased
in Fh1-deficient cells (Figure 4G). To further demonstrate a
defect in the biogenesis of the Fe-S cluster, we used mito-
Venus-GRX2, a well-established probe whose fluorescence de-
pends on the abundance of mitochondrial Fe-S clusters (Hoff
et al., 2009). Importantly, mito-Venus-GRX2 fluorescence, which
exhibited a typical mitochondrial staining (Figure S1I), wasmark-
edly reduced in Fh1-deficient cells (Figures 4H and 4I). Together,
these data suggest that succination of the Fe-S cluster promoted
by fumarate leads to defects in Fe-S cluster biogenesis, which
could explain the defects in RC complex I that we determined
in FH-deficient cells.
Mitochondrial Potential Maintenance in FH-Deficient
Cells
To investigate whether the observed RC defects have a func-
tional consequence on mitochondrial bioenergetics, we used
the potentiometric probe tetramethyl rhodamine ethyl ester1042 Cell Reports 21, 1036–1047, October 24, 2017(TMRE) to measure the mitochondrial membrane potential.
Surprisingly, FH-deficient cells showed a higher accumulation
of TMRE in the matrix than their FH-proficient counterparts (Fig-
ure 5A), suggesting that they have a higher mitochondrial mem-
brane potential (DJ) despite having substantial defects in RC
activity. To further investigate these findings, we set out to quan-
tify theDJ and the pH gradient (DpH) across the inner mitochon-
drial membrane, using multi-wavelength spectrophotometry
(Kim et al., 2012; Ripple et al., 2013). This analysis revealed
that, while DJ is indeed elevated in these cells, in line with our
imaging analyses, DpH is decreased (Figure 5B) such that the
proton motive force (DP), which is the sum of the two, remains
constant. The decrease in DpH is consistent with a decreased
matrix pH. Given that the activity of the TCA cycle does not
change the pH of the matrix per se, because protons there
generated are consumed by the electron transport chain (ETC),
it is likely that the high matrix concentration of fumarate and
the associated H+ are major contributors to matrix pH.
The spectrophotometry approach also revealed that, while the
redox potentials of the NAD+/NADH couple and cytochrome c
are not significantly different, the ubiquinone/ubiquinol couple
Figure 6. Fh1-Deficient Cells Are Resistant to RC Inhibition and Hypoxia
(A–C) Proliferation profile of the indicated cell lines in the presence of various ETC inhibitors (A), in 21% and 1% oxygen conditions (B), or in response to
the indicated mitochondria inhibitors (C). Data were obtained from at least 2 independent cultures and presented as mean ± SD.is markedly more oxidized in Fh1-deficient cells (Figure 5C),
consistent with combined defects for complexes I and II; and it
confirmed that the electron flux, measured as the number of
electrons transferred per complex III per second, is decreased
in Fh1-deficient cells (Figure 5D). Together, these results indicate
that the overall flux of electrons through the RC is decreased in
Fh1-deficient cells and that there is a different contribution of
DJ and DpH to DP.
Finally, to test whether FH-deficient cells are less dependent
on mitochondrial function for cell survival, we treated FH-defi-
cient cells with a number of RC inhibitors and measured cell
growth. As expected from cells adapted to mitochondrial
dysfunction, mouse and human FH-deficient cells were more
resistant to RC inhibition (Figures 6A and S3A) and their growth
was unimpeded in low-oxygen conditions (Figures 6B and
S3B). Of note, Fh1-deficent cells were resistant to metformin
and rotenone, confirming that complex I is not completely func-
tional. Interestingly, mouse Fh1-deficient cells were sensitized to
RC inhibitors in the presence of oligomycin (Figures 6C), consis-
tent with the fact that they still need some contribution of com-
plex V for ATP generation.
DISCUSSION
There is increasing recognition that alterations in cellular meta-
bolism underlie crucial aspects of oncogenesis. The clearest ex-
amples of this are seen frommutations in FH, SDH, and isocitrate
dehydrogenase (IDH1/2), which give rise to accumulation of the
oncometabolites fumarate, succinate, and 2-hydroxyglutarate,respectively (Baysal et al., 2000; Dang et al., 2009; Niemann
and M€uller, 2000; Tomlinson et al., 2002). In fact, tumor-associ-
ated cellular properties can be elicited by treatment with these
oncometabolites in the absence of tumorigenic mutations (Los-
man et al., 2013; Sciacovelli et al., 2016). Another well-docu-
mented and highly prevalent feature of tumor metabolism is
the observation that respiratory dysfunction often accompanies
theWarburg effect, which is recognized as a pervasive feature of
tumors. In this study, we sought to provide a mechanistic link
among FH loss, the accumulation of fumarate, and the ensuing
mitochondrial dysfunction.
FH loss impairs TCA cycle activity and decreases the rate at
which NADH and succinate are generated for use by the RC,
decreasing oxygen consumption even if the RC components
are functional. Thus, loss of FH activity would be expected to
result in a loss of electrons (oxidation) from the mitochondrial
NAD+/NADH and fumarate/succinate pools. Yet, this hypothesis
has not been formally tested. Here, we performed a comprehen-
sive bioenergetics analysis of mouse Fh1-deficient cells and
observed a modest (z16 mV) oxidation in the NAD+/NADH
pool (Figure 5C), and oxidation of the fumarate/succinate pool
was inferred from the increase in cytosolic fumarate. These cells
alsomaintain the sameDP as Fh1-proficient cells, that is, there is
the same amount of energy available for ATP generation by the
ATP synthase in both cell types. Oxygen consumption and
ATP production are tightly coupled by the relative stoichiometry
of the proton-pumping complexes and the ATP synthase, such
that a decrease in oxygen consumption and electron flux implies
a decrease in mitochondrial ATP production. As the rate of ATPCell Reports 21, 1036–1047, October 24, 2017 1043
production and consumption must also be matched, the results
imply either that the Fh1-deficient cells have decreased ATP de-
mand or that the shortfall is made up by increased glycolysis and
glycolytic ATP production. The latter scenario is corroborated by
previous analyses (Frezza et al., 2011; Yang et al., 2012).
The observation that the oxidation in the UQ/UQH2 (z39 mV)
is much more substantial (Figure 5C) than the oxidation in the
NAD+/NADH pool is consistent with combined defects with
complex I and complex II. Indeed, measurement of RC activity
showed that complex I activity is decreased in both human
and mouse FH-deficient cells, due to incomplete formation and
assembly of the Fe-S clusters because of succination of proteins
involved in Fe-S cluster biogenesis, including Iscu, Bola1-3, and
Nfu1. Although in human cells we confirmed the succination of
NFU1, in these cells we also observed a general suppression
of nuclear-encoded mitochondrial genes, which likely contrib-
utes the observed respiratory defects. We also demonstrated
that complex II activity is lowered by product inhibition due to
aberrant fumarate accumulation. Complex II contains three
Fe-S clusters; therefore, the observation that its activity is intact,
when assessed in cell extracts of Fh1-deficient cells, indicates
that the defects in Fe-S cluster generation are modest and affect
complex I, which contains the highest number of Fe-S clusters
among RC complexes, more strongly than complex II. The
observed upregulation of SDH assembly factors could also
compensate for the decrease in Fe-S cluster biogenesis,
increasing the efficiency of their incorporation in the mature
protein.
Several reasons could explain the different mitochondrial pro-
files of human and mouse cells. First, the human cells express a
mutant FH (Yang et al., 2012) whose role and function is not
completely understood, while the mouse cells are knocked out
for Fh1. Also, the different succination profile of Fe-S cluster
biogenesis proteins could be explained by the different levels
of accumulation of fumarate in these different cell lines (Zheng
et al., 2013). In this scenario, NFU1 seems to be more suscepti-
ble to succination than Iscu and Bola1/3. Interestingly, Nfu1 suc-
cination was identified in T cells treated with fumarate derivatives
(Blewett et al., 2016), confirming its vulnerability to succination.
The hypothesis that mouse cells exhibit stronger defects in
Fe-S cluster biogenesis is also confirmed by the fact that they
exhibit inhibition and succination of Aco2 (Ternette et al.,
2013), while human cells appear to have intact aconitase activity,
as indicated by their ability to perform reductive carboxylation
(Mullen et al., 2011). Although the decrease of Aco2 activity
has been previously ascribed to succination of cysteine residues
involved in Fe-S binding (Ternette et al., 2013), the availability of
these residues for succination is more likely the consequence of
an early defect in Fe-S assembly. Finally, additional mutations
could be present in UOK262 cells, which could explain the
transcriptional suppression of mitochondrial enzymes that we
observed. These results are similar to those observed in another
HLRCC cell line, UOK268, where a genetic suppression of all RC
components was observed (Yang et al., 2012). Therefore, more
work is required to fully understand the determinants of this tran-
scriptional reprogramming in these cells.
In conclusion, our comprehensive characterization of mito-
chondrial function in mouse and human FH-deficient cells1044 Cell Reports 21, 1036–1047, October 24, 2017showed that the loss of a single TCA cycle enzyme is sufficient
to alter RC activity via multiple mechanisms, underlining the
complex feedback system that controls mitochondrial function
in pathophysiological conditions. Interestingly, the metabolic
phenotype of FH-deficient cells can more effectively resist
conditions that are otherwise unfavorable formitochondrial func-
tion, including hypoxia, suggesting that these changes might be
selected during tumor progression.
EXPERIMENTAL PROCEDURES
Cell Culture
Cells were cultured in media supplemented with 10% heat-inactivated fetal
bovine serum (FBS). Mouse cells were cultured in high-glucose DMEM
(41966, Gibco) supplemented with uridine at a final concentration of
50 mg/mL (Sigma). UOK262 and UOK262pFH cells were cultured in the
same medium as Fh1 cells but without supplemental uridine. For hypoxia
experiments, cells were initially grown in normoxia for 24 hr and then trans-
ferred into 1% oxygen in an InViVO2 Hypoxia Workstation 500, for the indi-
cated amount of time.
Cell Counting in 21% and 1% O2
Equal numbers of cells were seeded in 6-well plates and cultured in either 21%
or 1% O2 conditions. At the indicated time points, cells were trypsinized and
counted on a Vi-CELL XR (Beckman Coulter), and viability was assessed by
the exclusion of trypan blue dye.
Proliferation on Galactose and ETC Inhibitors
Proliferation of cells in the presence of various ETC inhibitors or glucose-defi-
cient medium supplemented with galactose was monitored using an IncuCyte
Zoom instrument (Essen Bioscience).
Multi-wavelength Spectrometry
Heme absorption and NADH fluorescence measurements have been
described previously (Ripple et al., 2013). In brief, cells were cultured in
T175 flasks in phenol red-free DMEM. The cells were washed twice with
PBS, detached with TripLE Express (Themo Fisher Scientific), and then the
TrypLE was quenched with DMEM supplemented with 10% FBS. Cells were
spun down at 500 3 g for 5 min and re-suspended in FluoroBrite DMEM
(Themo Fisher Scientific) supplemented with 4 mM glutamine at a density of
107 cells/mL. Studies were carried out in a stirred 5-mL chamber maintained
at 37C. Oxygen consumption, at constant oxygen tension, was calculated
from the rate of the diffusion of oxygen across 80 mm of fine-bore oxygen-
permeable silicone tubing immersed in the cell suspension. Optical spectra
were collected on two time-multiplexed 0.3-m spectrographs (Triax 320;
Horiba, Edison, NJ), each equipped with a 1,024 3 128 pixel back-thinned
charge-coupled device camera (DV401BV; Andor Technology, SouthWindsor,
CT). NADH fluorescence was excited with a high power 365 nm LED (Nichia,
Japan), and spectra were collected between 390 and 661 nm using a
300-g/mm grating blazed at 500 nm with the slits set to a spectral resolution
of 10 nm. The cell suspension was illuminated with a high-power cool white
LED (Lumileds, USA), and heme absorption spectra were collected between
509 and 640 nm using a 600-g/mm grating blazed at 500 nm with slits set to
a spectral resolution of 1 nm.
The contribution of each heme/fluorophore to the spectra was calculated
using linear multi-wavelength least-squares fitting. The oxidation state and
content of the hemes and the oxidation state of mitochondrial NADH pool
were back-calculated from the fully reduced state and the fully oxidized
state. The fully reduced state was obtained by making the cells anoxic for
2 min at the beginning of the study, and the mitochondrial NADH pool was
fully oxidized by inhibiting the TCA cycle with 1 mM of the complex II inhibitor
3-nitropropionic acid and adding 1 mM carbonyl cyanide m-chlorophenyl
hydrazine (CCCP) at the end of the study. The hemes were fully oxidized
by the subsequent addition of 1 mM rotenone. The residual oxygen consump-
tion after the addition of rotenone was assumed to be non-mitochondrial and
subtracted from the total oxygen consumption to give the mitochondrial
oxygen consumption. The electron flux through complex III was calculated
by scaling the mitochondrial oxygen consumption by 4 electrons per O2
and normalizing to the content of complex III measured from the content
of the b-hemes. The redox potentials of the mitochondrial NAD+/NADH
pool and cytochrome c were calculated from the Nernst equation with
midpoint potentials of 320 and + 260 mV, and the former was corrected
for the pH of the matrix using the pH gradient assuming the cytosol remained
at pH 7.0. The redox potentials of the ubiquinone pool, the membrane poten-
tial (Dc), and the pH gradient (DpH) were calculated from the redox poise of
complex III, as described previously (Kim et al., 2012). The proton motive
force (Dp) is the sum of Dc and DpH.
Proteomic Analysis
Sample Dissolution and Protein Digestion
Cell pellets were dissolved in 0.1% SDS and 0.1 M Triethylammonium bicar-
bonate (TEAB) followed by probe sonication. Protein concentration was
measured with the Quick start Bradford assay (Bio-Rad). A total 90 mg protein
per sample was reduced with 2 mL 50-mM tris-2-carboxymethyl phosphine
(TCEP) (Sigma) at 60C for 1 hr. Cysteine residues were blocked with 1 ml
200-mM methyl methanethiosulfonate (MMTS) (Sigma) for 10-min incubation
at room temperature. For protein digestion, 6 ml trypsin solution (Roche) in
0.1% F.A (500 ng/mL) was added to each sample for overnight proteolysis.
TMT Labeling and bRP Fractionation
TMT10plex labeling reagents (Thermo Scientific) were reconstituted in 41 mL
anhydrous acetonitrile and transferred to each sample followed by incuba-
tion for 1 hr at room temperature. The reaction was quenched with 8 mL
5% hydroxylamine. The peptide mixture was fractionated with high-pH
reversed-phase chromatography on a C18 column (Waters, X-bridge).
Mobile phase (A) was composed of 20 mM ammonium hydroxide and mobile
phase (B) was composed of 80% acetonitrile and 20 mM ammonium hydrox-
ide. The gradient elution method at a flow rate of 200 mL/min was as follows:
for 10 min gradient up to 5% (B), for 35 min gradient up to 35% (B), for
10 min up to 50% (B), for 10 min up to 95% (B), for 10 min isocratic to
95% (B), for 5 min down to 5% (B), and for 10 min isocratic equilibration
5% (B) at 40C. Fractions were collected in a peak-dependent manner and
were dried with a vacuum concentrator.
Liquid Chromatography-Mass Spectrometry Analysis
The peptide fractions were analyzed on a Dionex Ultimate 3000 UHPLC sys-
tem coupled with Q-Exactive mass spectrometer (Thermo Scientific). The
RP fractions were reconstituted in 40 mL loading solution (2% acetonitrile
and 0.1% formic acid), and a 4-mL volume was loaded on the Acclaim PepMap
100, 100 mm 3 2 cm C18, 5 mm, 100 A˙ trapping column with the ulPickUp In-
jection mode using the loading pump at a 4 mL/min flow rate for 10min. For the
peptide separation, the Acclaim PepMap RSLC, 75 mm 3 50 cm, nanoViper,
C18, 3 mm, 100 A˙ column retrofitted to an easy source was used for multi-
step gradient elution. Mobile phase (A) was composed of 2% acetonitrile,
0.1% formic acid, and 5% DMSO and mobile phase (B) was composed of
80% acetonitrile, 0.1% formic acid, and 5% DMSO. The gradient elution
method at a flow rate of 300 nL/min was as follows: for 10 min gradient up
to 5% (B), for 85 min gradient up to 45% (B), for 5 min up to 95% (B), for
8 min isocratic to 95% (B), for 2 min down to 5% (B), and for 10 min isocratic
equilibration 5% (B) at 40C. The top 10 precursors were selected with Fourier
transform (FT) mass resolution of 70,000 and isolated for higher-energy
collisional dissociation (HCD) fragmentation with collision energy of 33 and
FT resolution of 35,000.
Database Search
The acquired tandem mass spectrometry (MS/MS) mass spectra were pro-
cessed with SequestHT implemented on the Proteome Discoverer software
version 2.1 for peptide and protein identifications against a UniProtKB/
Swiss-Prot fasta file containing 21,530 reviewed human entries or 17,000
reviewed mouse entries. The SequestHT node included the following param-
eters: Precursor Mass Tolerance 20 ppm, Fragment Mass Tolerance
0.02 Da, Dynamic Modifications were Oxidation of M (+15.995 Da), Deamida-
tion of N, Q (+0.984 Da), Methylthio of C (+45.988), and 2-succinyl cysteine
(+116.011). The Static Modifications were TMT6plex at any N terminus and
K (+229.163 Da). The level of confidence for peptide identifications wasestimated with the Percolator node with decoy database search. FDR was
set at 0.01 based on q-value. The Reporter Ion Quantifier node included a
custom TMT 10plex (Thermo Scientific Instruments) Quantification Method,
integration window tolerance of 20 ppm, and the Most Confident Centroid
integration method.
Statistical Analysis
Protein quantification was normalized on total peptide amount, and the FH-
deficient conditions were compared to the wild-type (WT) FH cells with
ANOVA test using the Perseus proteomics data analysis tool (Tyanova
et al., 2016). Significant hits were filtered using permutation-based FDR
(<1% for total proteome and <5% for succinylated peptides). Volcano plots
and scatterplots were drawn in R studio using the ggplot2 package. Heat-
maps of proteomics data from mouse and human cells were generated
with R studio.
RNA Sequencing Analyses
RNA sequencing (RNA-seq) data of UOK262 and UOK262-pFH cells (GEO:
GSE77542) were obtained from Sciacovelli et al. (2016). Data were log normal-
ized using the R package DEseq2, and gene expression data of RC complexes
were plotted with heatmap representation.
Respirometry Experiments
All respirometry measurements were performed using an XFe24 Analyzer
(Agilent Technologies, formerly Seahorse Bioscience) according to the manu-
facturer’s instructions. For experiments on intact cells, injections of various
compounds were performed as indicated in the figures. For experiments on
permeabilized cells, cell membranes were permeabilized using the Seahorse
XF PlasmaMembrane Permeabilizer (PMP) reagent according to themanufac-
turer’s instructions. The contribution of each complex to respiration was deter-
mined by injections of various compounds, as described by Salabei et al.
(2014). Following all respirometry measurements, cells in each well were
disrupted in radioimmunoprecipitation assay (RIPA) buffer and protein was
measured using the bicinchoninic acid (BCA) assay (Thermo Fisher
Scientific). Oxygen consumption rates from each well were normalized to
the protein abundance of that well or to the average of the wells relative to
that group.
Complex I Activity Assay
Complex I in-gel flavin-site activity assay was measured as indicated in Wittig
et al. (2007) using 100 mg isolated mitochondria separated in NativePAGE 3%–
12% Bis-Tris Gel System. Gels were scanned and the intensity of complex
I activity was measured using ImageJ. Respiration mediated by complex
I on isolated mitochondrial membranes from bovine heart was measured as
described in Bridges et al. (2014).
SQR Assay
SQR measurements were performed as described by Selak et al. (2005) with
minor modifications. Cells were permeabilized with 0.1% v/v Triton X-100 in
a buffer with 25 mM KHPO4 (pH 7.4), 1–25 mM succinate, 50 mM decylubiqui-
none, 5 mM rotenone, 2 mM antimycin A, and 10 mM NaN3. Different concen-
trations of fumarate were also included in the buffer, as indicated in the figures.
After a 15-min incubation at room temperature, a baseline absorbance at
600 nm was measured and the reaction started by adding 100 mM 26-dichlor-
ophenolindophenol (DCIP) (e = 21 mM1 cm1). The change in absorbance
was monitored for 2 min before and after the addition of 50 mM 2-thenoyltri-
fluoroacetone (TTFA), a complex II inhibitor used to confirm reaction speci-
ficity. The TTFA-sensitive SQR activity is reported as nmol/min DCIP/0.6 3
106 cells. Fumarate levels at the end of SQR experiments were measured
by 1H nuclear magnetic resonance (1H NMR) spectroscopy. This was
performed with solvent suppression on a 600-MHz Brucker Avance NMR
spectrometer. 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was used as
an internal standard, and the Electronic Reference to Access In Vivo Concen-
tration (ERETIC) method (Akoka et al., 1999) was used to determine the con-
centration of DSS in each sample. Processing of NMR spectra included both
zero- and first-order phase corrections followed by baseline correction using
the ChenomxNMRSuite 7.6. Fumarate was identified, based on chemical shift
assignment, also using the Chenomx NMR Suite 7.6. The concentration ofCell Reports 21, 1036–1047, October 24, 2017 1045
fumarate was determined by normalizing peak area to a known concentration
of DSS in each sample.
Flow Cytometry Measurements
6 3 105 cells were plated onto 6-cm dishes. The day after, cells were trans-
fected using Lipofectamine 2000, following the manufacturer’s instructions
and Fe-S constructs N173-GRX2 and C155-GRX2 as described before (Hoff
et al., 2009). After 48 hr, cells were washed in PBS and detached using trypsin.
After centrifugation at 1,0003 g for 5 min, cells were resuspended in complete
medium and analyzed by fluorescence-activated cell sorting (FACS) using an
LSR II flow cytometer (BD Biosciences). Venus fluorescence was measured
using a 488-nm laser for excitation using 50-mW power; emission was
measured using a (488) 530/30 detector. 1 3 105 events were acquired for
each sample. Graphs presented were generated using FlowJo software.
Aconitase Activity Assay
The activity of aconitase in Fh1-deficient cells was measured using the Aconi-
tase Assay Kit (Cayman), following the manufacturer’s instruction.
Microscopy
Cells were grown in m-Slide 8Well vessels (ibidi) in mediumwithout phenol red.
Live cells were stained with 50 nM MitoTracker Green (MTG) (Invitrogen) and
10 nM TMRE (Invitrogen) for 1 hr at 37C in complete media with 25 mM
HEPES (pH 7.4). Cells were maintained at 37C and 5% CO2 in a stage top
incubator (Tokai Hit). Images were acquired using a Leica TCS SP5 (Leica
Microsystems, Wetzlar, Germany) equipped with a 203 objective. Acquisition
was performed in a sequential scanning mode. MTG was excited using the
488-nm laser and TMRE using the 543-nm laser. MTG emission was collected
from 500 to 545 nm and TMRE emission from 580 to 620 nm. TMRE intensity
from images was quantified using Columbus Image Data Storage and Analysis
System (PerkinElmer). For mito-Venus-GRX2 constructs, 8 3 104 or 1 3 105
cells were plated on Nunc Lab-Tek Chambered Coverglass (1.0 borosilicate
glass). The day after, cells were transfected with Lipofectamine 2000 (Invitro-
gen), following the manufacturer’s instructions, and mito-Venus Fe-S sensor
constructs N173-GRX2 and C155-GRX2. After 16 hr, medium was replaced
with a fresh one and images were acquired using a Leica TCS SP5 (Leica
Microsystems, Wetzlar, Germany) equipped with a 633 oil UV objective. The
Venus construct was excited using Argon laser (514 nm) as described before
(Hoff et al., 2009). Microscope settings were kept constant during the acquisi-
tion of all images.
Statistical Analysis
Statistical analyses were performed in GraphPad Prism 6 software. Pairwise
comparisonswere assessedusing anunpaired two-tailedStudent’s t test.Mul-
tiple comparisons were assessed with one-way ANOVA, including Tukey post
hoc test for multiple testing, if not indicated otherwise. Error bars are shown as
indicated in figure legends and all experiments were performed at least twice.
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